{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:50:22Z","timestamp":1792979422367,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.biopha.2017.07.098","type":"journal-article","created":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T19:48:39Z","timestamp":1502912919000},"page":"1138-1144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["MiRNA-21 has effects to protect kidney injury induced by sepsis"],"prefix":"10.1016","volume":"94","author":[{"given":"Dian","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaopeng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenquan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.07.098_bib0005","first-page":"856401","article-title":"Sepsis and AKI in ICU patients: the role of plasma biomarkers","volume":"2012","author":"Lentini","year":"2012","journal-title":"Crit. Care Res. Pract."},{"issue":"2","key":"10.1016\/j.biopha.2017.07.098_bib0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2017.07.098_bib0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing: often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.biopha.2017.07.098_bib0020","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.biopha.2017.07.098_bib0025","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancer","volume":"101","author":"Calin","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.biopha.2017.07.098_bib0030","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.cell.2006.02.037","article-title":"A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors","volume":"124","author":"Voorhoeve","year":"2006","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.biopha.2017.07.098_bib0035","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","article-title":"RAS is regulated by the let-7 microRNA family","volume":"120","author":"Johnson","year":"2005","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biopha.2017.07.098_bib0040","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.3892\/or.2014.3478","article-title":"MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2","volume":"32","author":"Wang","year":"2014","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2017.07.098_bib0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","article-title":"Unique microRNA molecular prolifes in lung cancer diagnosis and prognosis","volume":"9","author":"Yanaihara","year":"2006","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.biopha.2017.07.098_bib0050","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3892\/mmr.2014.2366","article-title":"Transforming growth factor beta 1 induces epithelial mesenchymal transition and increased expression of matrix metalloproteinase 16 via miR-200b downregulation in bladder cancer cells","volume":"10","author":"Chen","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2017.07.098_bib0055","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.canlet.2013.06.018","article-title":"miR-146b-5p inhibits slioma migration and invasion by targeting MMP 16","volume":"339","author":"Li","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2017.07.098_bib0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/10641955.2013.792346","article-title":"Coagulation fibrinolysis and laboratory characteristics of pregnant women with severely depressed antithrombin activity","volume":"32","author":"Yamada","year":"2013","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.biopha.2017.07.098_bib0065","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1447-0756.2010.01191.x","article-title":"Marked gestational edema as a clinical sign of life-threatening condition","volume":"36","author":"Koyama","year":"2010","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.biopha.2017.07.098_bib0070","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/jog.12282","article-title":"Differentiation of acute fatty liver of pregnancy from syndrome of hemolysis, elevated liver enzymes and low platelet counts","volume":"40","author":"Minakami","year":"2014","journal-title":"Obstet. Gynaecol. Res."},{"key":"10.1016\/j.biopha.2017.07.098_bib0075","first-page":"141","article-title":"Antithrombin activity, platelet count, hemoglobin concentration and hematocrit value determined immediately before vaginal delivery among healthy women","volume":"87","author":"Morikawa","year":"2012","journal-title":"Hkkaido Igaku Zasshi"},{"issue":"1","key":"10.1016\/j.biopha.2017.07.098_bib0080","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"issue":"September","key":"10.1016\/j.biopha.2017.07.098_bib0085","article-title":"Renal protection mediated by hypoxia inducible factor-1 \u03b1 depends on pro-angiogenesis function of miR-21 by targeting thrombospondin 1","author":"Xu","year":"2016","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.biopha.2017.07.098_bib0090","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1089\/dna.2016.3231","article-title":"Upregulation of miR-21 by ghrelin ameliorates ischemia\/reperfusion-induced acute kidney injury by inhibiting inflammation and cell apoptosis","volume":"35","author":"Zhang","year":"2016","journal-title":"DNA Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2017.07.098_bib0095","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yexcr.2015.08.010","article-title":"miR-21 inhibits autophagy by targeting Rab11a in renal ischemia\/reperfusion","volume":"338","author":"Liu","year":"2015","journal-title":"Exp. Cell Res."},{"issue":"4","key":"10.1016\/j.biopha.2017.07.098_bib0100","first-page":"3735","article-title":"Trimetazidine protects against hypoxia-reperfusion-induced cardiomyocyte apoptosis by increasing microRNA-21 expression","volume":"8","author":"Yang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"11","key":"10.1016\/j.biopha.2017.07.098_bib0105","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s13238-013-3085-y","article-title":"microRNA-21 in the pathogenesis of acute kidney injury","volume":"4","author":"Li","year":"2013","journal-title":"Protein Cell"},{"issue":"3","key":"10.1016\/j.biopha.2017.07.098_bib0110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/cvr\/cvq196","article-title":"miR-21: a miraculous Socratic paradox","volume":"87","author":"da Costa Martins","year":"2010","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.biopha.2017.07.098_bib0115","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.3892\/mmr.2014.2068","article-title":"microRNA-21 protects against ischemia-reperfusion and hypoxia-reperfusion-induced cardiocyte apoptosis via the phosphatase and tensin homolog\/AKT-dependent mechanism","volume":"9","author":"Yang","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2017.07.098_bib0120","doi-asserted-by":"crossref","first-page":"e0117400","DOI":"10.1371\/journal.pone.0117400","article-title":"Ursolic acid attenuates diabetic mesangial cell injury through the up-regulation of autophagy via miRNA-21\/PTEN\/Akt\/mTOR suppression","volume":"10","author":"Lu","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.biopha.2017.07.098_bib0125","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.jpedsurg.2014.09.009","article-title":"MicroRNA-21\/PTEN\/Akt axis in the fibrogenesis of biliary atresia","volume":"49","author":"Shen","year":"2014","journal-title":"J. Pediatr. Surg."},{"issue":"30","key":"10.1016\/j.biopha.2017.07.098_bib0130","doi-asserted-by":"crossref","first-page":"28867","DOI":"10.18632\/oncotarget.4814","article-title":"MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN\/Akt pathway","volume":"6","author":"He","year":"2015","journal-title":"Oncogarget"},{"key":"10.1016\/j.biopha.2017.07.098_bib0135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejphar.2016.04.001","article-title":"Ursolic acid induced anti-proliferation effects in rat primary vascular smooth muscle cells is associated with inhibition of microRNA-21 and subsequent PTEN\/PI3K","volume":"781","author":"Jiang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2017.07.098_bib0140","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ajpath.2013.06.032","article-title":"miR-21-containing microvesicles from injured tubular epithelial cells promote tubular phenotype transition by targeting PTEN protein","volume":"138","author":"Zhou","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2017.07.098_bib0145","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbrc.2006.09.077","article-title":"PTEN enhance TNF-induced apoptosis through modulation of nuclear factor-kappa B signaling pathway in human glioma cells","volume":"350","author":"Koul","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2017.07.098_bib0150","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/156800908784293659","article-title":"The PTEN\/PI3K\/AKT signaling pathway in cancer: therapeutic implications","volume":"8","author":"Carnero","year":"2008","journal-title":"Curr. Cancer Drug Targets"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217330287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217330287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:18:42Z","timestamp":1776381522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217330287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":30,"alternative-id":["S0753332217330287"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.07.098","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiRNA-21 has effects to protect kidney injury induced by sepsis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.07.098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}